Singh A, Sanghavi N, Bandari V, Khan I, Alfaraj A
Eur J Case Rep Intern Med. 2024; 11(10):004767.
PMID: 39372147
PMC: 11451846.
DOI: 10.12890/2024_004767.
Shen W, Kao H, Wang C, Kousar R, Lin J, Ko C
Int J Med Sci. 2024; 21(11):2158-2169.
PMID: 39239542
PMC: 11373554.
DOI: 10.7150/ijms.96134.
Fields B, Tzeng C
Surg Clin North Am. 2024; 104(5):1017-1030.
PMID: 39237161
PMC: 11748233.
DOI: 10.1016/j.suc.2024.03.004.
Domagala-Haduch M, Gorzelak-Magiera A, Michalecki L, Gisterek-Grocholska I
Curr Oncol. 2024; 31(6):3291-3300.
PMID: 38920733
PMC: 11202861.
DOI: 10.3390/curroncol31060250.
Girolimetti G, Pelisenco I, Eusebi L, Ricci C, Cavina B, Kurelac I
Noncoding RNA. 2024; 10(3).
PMID: 38804361
PMC: 11130804.
DOI: 10.3390/ncrna10030029.
Pancreatic SABR using peritumoral fiducials, triggered imaging and breath-hold.
Kisivan K, Farkas A, Kovacs P, Glavak C, Lukacs G, Mahr K
Pathol Oncol Res. 2024; 29:1611456.
PMID: 38188611
PMC: 10767757.
DOI: 10.3389/pore.2023.1611456.
Optimizing patient selection for stereotactic ablative radiotherapy in patients with locally advanced pancreatic cancer after initial chemotherapy - a single center prospective cohort.
Doppenberg D, Lagerwaard F, van Dieren S, Meijerink M, van der Vliet J, Besselink M
Front Oncol. 2023; 13:1149961.
PMID: 37324027
PMC: 10264658.
DOI: 10.3389/fonc.2023.1149961.
Current Approaches for the Curative-Intent Surgical Treatment of Pancreatic Ductal Adenocarcinoma.
Slodkowski M, Wronski M, Karkocha D, Kraj L, Smigielska K, Jachnis A
Cancers (Basel). 2023; 15(9).
PMID: 37174050
PMC: 10177138.
DOI: 10.3390/cancers15092584.
Analysis of Risk Factors for Distant Metastasis of Pancreatic Ductal Adenocarcinoma without Regional Lymph Node Metastasis and a Nomogram Prediction Model for Survival.
Huang J, Li X, Jiang Q, Qiu H, Rong Y, Cui B
Evid Based Complement Alternat Med. 2023; 2023:2916974.
PMID: 36865748
PMC: 9974279.
DOI: 10.1155/2023/2916974.
Collagen VI expression is negatively mechanosensitive in pancreatic cancer cells and supports the metastatic niche.
Papalazarou V, Drew J, Juin A, Spence H, Whitelaw J, Nixon C
J Cell Sci. 2022; 135(24).
PMID: 36546396
PMC: 9845737.
DOI: 10.1242/jcs.259978.
Epigenetics in Pancreatic Ductal Adenocarcinoma: Impact on Biology and Utilization in Diagnostics and Treatment.
Elrakaybi A, Ruess D, Lubbert M, Quante M, Becker H
Cancers (Basel). 2022; 14(23).
PMID: 36497404
PMC: 9738647.
DOI: 10.3390/cancers14235926.
Comparative efficacy and safety of neoadjuvant radiotherapy for patients with borderline resectable, and locally advanced pancreatic ductal adenocarcinoma: a systematic review and network meta-analysis protocol.
Lv W, Wang Q, Hu Q, Wang X, Cao D
BMJ Open. 2022; 12(7):e050558.
PMID: 35831044
PMC: 9280870.
DOI: 10.1136/bmjopen-2021-050558.
Improved survival with induction chemotherapy and conversion surgery in locally advanced unresectable pancreatic cancer: a single institution experience.
Su Y, Ting Y, Wang C, Chao Y, Liao T, Su P
Am J Cancer Res. 2022; 12(5):2189-2202.
PMID: 35693078
PMC: 9185606.
Application of Proteomics in Pancreatic Ductal Adenocarcinoma Biomarker Investigations: A Review.
Vellan C, Jayapalan J, Yoong B, Abdul-Aziz A, Mat-Junit S, Subramanian P
Int J Mol Sci. 2022; 23(4).
PMID: 35216204
PMC: 8879036.
DOI: 10.3390/ijms23042093.
Pancreatic Cancer Patient-Derived Organoid Platforms: A Clinical Tool to Study Cell- and Non-Cell-Autonomous Mechanisms of Treatment Response.
Piro G, Agostini A, Larghi A, Quero G, Carbone C, Esposito A
Front Med (Lausanne). 2022; 8:793144.
PMID: 35004765
PMC: 8733292.
DOI: 10.3389/fmed.2021.793144.
Results of a single-arm pilot study of P microparticles in unresectable locally advanced pancreatic adenocarcinoma with gemcitabine/nab-paclitaxel or FOLFIRINOX chemotherapy.
Ross P, Wasan H, Croagh D, Nikfarjam M, Nguyen N, Aghmesheh M
ESMO Open. 2021; 7(1):100356.
PMID: 34953400
PMC: 8717429.
DOI: 10.1016/j.esmoop.2021.100356.
Dosimetric Uncertainties Resulting From Interfractional Anatomic Variations for Patients Receiving Pancreas Stereotactic Body Radiation Therapy and Cone Beam Computed Tomography Image Guidance.
Niedzielski J, Liu Y, Ng S, Martin R, Perles L, Beddar S
Int J Radiat Oncol Biol Phys. 2021; 111(5):1298-1309.
PMID: 34400267
PMC: 8651043.
DOI: 10.1016/j.ijrobp.2021.08.002.
New Potential Options for SBRT in Pancreatic Cancer.
Ghaly M, Gogineni E, Herman J, Saif M
Cancer Med J. 2021; 4(Suppl 3):41-50.
PMID: 34355218
PMC: 8336074.
Dynamic Stromal Alterations Influence Tumor-Stroma Crosstalk to Promote Pancreatic Cancer and Treatment Resistance.
Murphy K, Chambers C, Herrmann D, Timpson P, Pereira B
Cancers (Basel). 2021; 13(14).
PMID: 34298706
PMC: 8305001.
DOI: 10.3390/cancers13143481.
Four-Tier Pathologic Tumor Regression Grading System Predicts the Clinical Outcome in Patients Who Undergo Surgical Resection for Locally Advanced Pancreatic Cancer after Neoadjuvant Chemotherapy.
Ahn S, Lee J, Kim J, Kim Y, Yoon Y, Han H
Gut Liver. 2021; 16(1):129-137.
PMID: 33875622
PMC: 8761920.
DOI: 10.5009/gnl20312.
